Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: CAR T therapies in multiple myeloma: unleashing the future

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000083

2. The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

   Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya +7

   Шарҳ мақолаImmune Cell Function and InteractionExperimental Cell Research20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000131